Document
... Human immunodeficiency virus Leads to AIDS (Acquired immunodeficiency syndrome) HIV is spread through sexual contact, or from a parent that has the disease ...
... Human immunodeficiency virus Leads to AIDS (Acquired immunodeficiency syndrome) HIV is spread through sexual contact, or from a parent that has the disease ...
HIV Associated TB: A Major Public Health Challenge Mitzi Nisbet
... Co-infection with tuberculosis (TB) and human immunodeficiency virus (HIV) poses a tremendous challenge to TB control, especially in resource-limited settings. Among the estimated 8.7 million new TB cases in 2011, 1.1 million (13%) had HIV infection. Co-infection with HIV leads to challenges in both ...
... Co-infection with tuberculosis (TB) and human immunodeficiency virus (HIV) poses a tremendous challenge to TB control, especially in resource-limited settings. Among the estimated 8.7 million new TB cases in 2011, 1.1 million (13%) had HIV infection. Co-infection with HIV leads to challenges in both ...
Unofficial translation
... access to information other than that which existed at the district court. The Court of Appeal has obtained an expert opinion from the Swedish Institute for Infectious Disease Control (SMI) regarding the risk of transmission of HIV through unprotected sexual intercourse. Furthermore, Professor Jan A ...
... access to information other than that which existed at the district court. The Court of Appeal has obtained an expert opinion from the Swedish Institute for Infectious Disease Control (SMI) regarding the risk of transmission of HIV through unprotected sexual intercourse. Furthermore, Professor Jan A ...
ImQuest Life Sciences Receives FDA Approval to Initiate Clinical
... President and Chief Scientific Officer of ImQuest. “We hope that the IQP‐0528 containing gel will be a highly successful prevention agent and will be a first step towards development of subsequent products, including our DuoGel™ for protection of both vaginal and rectal virus trans ...
... President and Chief Scientific Officer of ImQuest. “We hope that the IQP‐0528 containing gel will be a highly successful prevention agent and will be a first step towards development of subsequent products, including our DuoGel™ for protection of both vaginal and rectal virus trans ...
HIV/AIDS Exam Questions
... 2. Which of the following characteristics does not apply to viruses? A. Incapable of independent reproduction B. Obligate intracellular parasite C. Cell wall, capsule, ribosomes, flagella, cytoplasm D. Noncellular E. Tiny infectious particle 3. Which of the following sexually transmitted diseases (S ...
... 2. Which of the following characteristics does not apply to viruses? A. Incapable of independent reproduction B. Obligate intracellular parasite C. Cell wall, capsule, ribosomes, flagella, cytoplasm D. Noncellular E. Tiny infectious particle 3. Which of the following sexually transmitted diseases (S ...
Microbicides for sexually transmitted diseases
Microbicides for sexually transmitted diseases are pharmacologic agents and chemical substances that are capable of killing or destroying certain microorganisms that commonly cause human infection (for example, the human immunodeficiency virus).Microbicides are a diverse group of chemical compounds that exert their activity by a variety of different mechanisms of action.Multiple compounds are being developed and tested for their microbicidal activity in clinical trials. Microbicides can be formulated in various delivery systems including gels, creams, lotions, aerosol sprays, tablets or films (which must be used near the time of sexual intercourse) and sponges and vaginal rings (or other devices that release the active ingredient(s) over a longer period). Some of these agents are being developed for vaginal application, and for rectal use by those engaging in anal sex.Although there are many approaches to preventing sexually transmitted diseases in general (and HIV in particular), current methods have not been sufficient to halt the spread of these diseases (particularly among women and people in less-developed nations). Sexual abstinence is not a realistic option for women who want to bear children, or who are at risk of sexual violence. In such situations, the use of microbicides could offer both primary protection (in the absence of condoms) and secondary protection (if a condom breaks or slips off during intercourse). It is hoped that microbicides may be safe and effective in reducing the risk of HIV transmission during sexual activity with an infected partner.